Stefan Wilhelm
16 IP cases indexed. Covers patent matters.
Cases Presided Over
16 cases indexed | Page 1 of 1
Ecovacs Robotics Co., Ltd. v.Roborock (HK) Limited
Ecovacs obtained an ex parte inspection order from the Local Division Düsseldorf to inspect Roborock's robot vacuum cleaners at the IFA 2025 trade fair in Berlin in connection with patent EP 3 808 512. Upon Roborock's request for review, the Local Division revoked the inspection order, finding that Ecovacs had breached its duty under R. 192.3 RoP by failing to disclose that Roborock itself was selling the contested products directly to German customers via Amazon. The Court of Appeal upheld this decision, rejecting Ecovacs' appeal and ordering Ecovacs to bear Roborock's costs.
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited & Others
This order concerns a request for rectification of a decision on costs issued on 21 July 2025 in proceedings involving patent EP 3 769 722. The Defendants sought rectification, arguing that the Court had omitted to expressly order the Claimant to bear 25% of the Defendants' costs in the counterclaim for revocation proceedings. The Court dismissed the requests, holding that the original cost allocation (Defendants to reimburse 100% of the Claimant's costs in the infringement action and 75% in the counterclaim for revocation, without deduction for any share of the Defendants' costs) was a permissible and equitable distribution under Article 69 UPCA and did not constitute an obvious slip.
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited, VAB-Logistik UAB, SMIS International OÜ, Meril GmbH, Sormedica UAB, Interlux UAB
Edwards Lifesciences Corporation brought an infringement action against Meril Life Sciences and related entities concerning European Patent 3 769 722, which relates to a low profile delivery system for transcatheter heart valves. The defendants denied infringement and filed counterclaims for revocation, along with conditional applications to amend the patent. The Court of First Instance of the Unified Patent Court (Nordic-Baltic Regional Division) found the patent valid as amended, held that the defendants infringed claim 1, and ordered injunctive relief, corrective measures, provisional damages of EUR 500,000, and cost awards in favor of Edwards.
Tandem Diabetes Care Europe B.V. and Tandem Diabetes Care, Inc. v.Roche Diabetes Care GmbH
Tandem Diabetes filed a revocation action against Roche Diabetes Care GmbH before the Central Division Paris concerning European Patent EP 2 196 231, relating to a system for ambulatory drug infusion. The Central Division dismissed the revocation action and maintained the patent as granted, after which Tandem Diabetes appealed. Following the appeal, the parties reached a settlement and jointly requested the Court of Appeal to confirm it, which the Court did, terminating the appellate proceedings and confirming that each party bears its own costs.
Unnamed Applicant (Member of the Public) v.Meril Life Sciences PVT Limited (UPC_CFI_380/2023)
An unnamed member of the public, represented by Erik Krahbichler, applied for access to all written pleadings and evidence in infringement proceedings (UPC_CFI_380/2023) between Edwards Lifesciences Corporation and Meril et al. concerning EP 3 769 722. After the parties objected and Meril Life Sciences PVT Limited requested reimbursement of EUR 17,168.70 in legal costs, the Applicant withdrew the applications. The judge-rapporteur closed the proceedings on the access applications and dismissed the requests for reimbursement of legal costs, holding that Article 69 UPCA does not provide a legal basis for ordering a member of the public to reimburse costs incurred by parties consulted under Rule 262.1(b) RoP.
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited & Others
This procedural order from the Unified Patent Court concerns an infringement action by Edwards Lifesciences Corporation against several Meril entities and related companies regarding EP3769722. The Defendants requested a stay of proceedings pending the European Patent Office Opposition Division's decision on the patent's validity. After the Court of Appeal set aside an earlier order dismissing the stay request, the Court of First Instance again dismissed the stay request and decided to proceed with the oral hearing as planned on 16 January 2025.
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited, Meril GmbH, SMIS International OÜ, Sormedica UAB, Interlux UAB, VAB-Logistik UAB
This is a procedural order issued by the Court of First Instance of the Unified Patent Court (Nordic-Baltic Regional Division) in a patent infringement action concerning European Patent EP3769722. The order addresses multiple case management issues raised during an interim conference, including the value of the case, scheduling relative to parallel EPO opposition proceedings, admissibility of late-filed attacks on inventive step, and various other procedural requests. The Court set the total case value at 6,000,000 EUR, declined to reschedule the oral hearing, excluded certain late-filed inventive step attacks, and ruled on the admissibility of auxiliary requests, equivalence arguments, and expert-related requests.
SWAT Medical AB v.Meril Italy S.r.l., Edwards Lifesciences Corporation, Meril Gmbh, and Meril Life Sciences Pvt Ltd.
SWAT Medical AB and its board member/investor applied under Rule 262(1)(b) of the Rules of Procedure for public access to all pleadings and evidence in revocation proceedings concerning European patent EP 3 646 825. The respondents opposed the application, seeking rejection or limitations on access and confidentiality conditions. The Court of First Instance granted the applications, allowing access to all pleadings and evidence, but granted leave to appeal and suspended the effects of the order pending any appeal.
Meril Life Sciences Pvt Ltd. & Meril GmbH v.Edwards Lifesciences Corporation
This is an appeal decision from the Court of Appeal of the Unified Patent Court concerning the allocation of costs after Meril submitted a cease and desist declaration during provisional measures proceedings brought by Edwards Lifesciences over European Patent EP 3 763 331. The Court of Appeal held that when a defendant submits a cease and desist declaration after proceedings are initiated, the plaintiff is generally the prevailing party, and dismissed Meril's appeal, ordering Meril to bear the costs of the appeal proceedings.
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited & Others
This is a procedural order from the Nordic-Baltic Regional Division of the Unified Patent Court concerning an infringement action regarding EP3769722. The Defendants (Meril entities and others) requested a stay of proceedings pending an EPO opposition decision, while the Claimant (Edwards Lifesciences Corporation) opposed the stay. The Court dismissed the request, holding that Rule 118.2(b) RoP applies only during oral procedure, a rapid EPO decision could not be expected, and the UPC could itself decide validity given the pending counterclaims for revocation.
Meril Life Sciences Pvt Limited and Others v.Edwards Lifesciences Corporation
This procedural order from the Nordic-Baltic Regional Division of the Unified Patent Court concerns a request by the Defendants (Meril Life Sciences and related entities) for the Claimant (Edwards Lifesciences Corporation) to provide security for legal costs in an infringement action concerning EP3769722. The Defendants argued that security was warranted because the Claimant is based in the United States, outside the EU, making enforcement of any cost order potentially difficult. The court dismissed the application, holding that the Claimant's location outside the EU and the lack of experience enforcing UPC orders in the US are not sufficient grounds for ordering security, and that the balance of interests favored the Claimant.
Meril Italy Srl v.Edwards Lifesciences Corporation
This case concerns a revocation action filed by Meril Italy Srl and counterclaims for revocation filed by Meril GmbH and Meril Life Sciences Pvt Ltd against European patent EP 3 646 825, owned by Edwards Lifesciences Corporation, relating to prosthetic heart valves with sealing mechanisms. The patent proprietor submitted multiple requests to amend the patent during the proceedings, ultimately proposing one unconditional amendment and six auxiliary requests. The Court rejected the revocation action and counterclaims, maintaining the patent as amended by auxiliary request II, and ordered costs to be borne 60% by the claimant and counterclaimants jointly and 40% by the defendant.
Meril Italy Srl v.Edwards Lifesciences Corporation
This case concerned a revocation action filed by Meril Italy Srl and counterclaims for revocation filed by Meril GmbH and Meril Life Sciences Pvt Ltd against European Patent EP 3 646 825, owned by Edwards Lifesciences Corporation, which relates to prosthetic heart valves with sealing mechanisms. The claimants and counterclaimants challenged the patent's validity on grounds including added subject matter, lack of enabling disclosure, lack of novelty, and lack of inventive step. The Court rejected the revocation action and counterclaims, maintaining the patent as amended by auxiliary request II submitted by the defendant during the proceedings, and ordered costs to be borne 60% by the claimants/counterclaimants and 40% by the defendant.
Meril Italy Srl v.Edwards Lifesciences Corporation
Meril Italy Srl filed a revocation action against Edwards Lifesciences Corporation concerning European patent EP 3 646 825, which relates to prosthetic heart valves with sealing mechanisms. Meril GmbH and Meril Life Sciences Pvt Ltd filed counterclaims for revocation in related infringement proceedings before the Munich Local Division, which were transferred to the Central Division Paris. The Court rejected the revocation action and counterclaims, maintaining the patent as amended by auxiliary request II submitted by Edwards, with costs split 60% against the claimants/counterclaimants and 40% against the defendant.
Edwards Lifesciences Corporation v.Meril Italy srl
This order concerns a subsequent request by the patent proprietor (Edwards Lifesciences Corporation) to amend European patent EP 3 646 825 in revocation proceedings brought by Meril Italy srl. The defendant sought to replace its earlier rejected application (containing 84 auxiliary requests) with a streamlined request comprising one unconditional amendment and six auxiliary requests. The Court admitted the subsequent request, exercising its discretionary powers under Rule 30(2) RoP, and granted the claimant one month to file an additional defence.
BITZER Electronics A/S v.Carrier Corporation
This is an order from the Court of First Instance of the Unified Patent Court (Central Division, Paris Seat) issued on 5 April 2024 in a revocation action concerning European patent EP 3 414 708. Following an interim conference held on 2 April 2024, the judge-rapporteur set out procedural decisions regarding the validity of the priority claim, the admissibility of amendments, late-filed attacks, the value of the proceedings, and the scheduling of the oral hearing.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.